Related content

Poor prognosis for ovarian response to stimulation: results of a randomised trial comparing the flare-up GnRH agonist protocol vs. the antagonist protocol

By Devesa Marta   Martínez Francisca   Coroleu Buenaventura   Tur Rosa   González Clara   Rodríguez Ignacio   Barri Pedro N.  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 509-515

Informa Healthcare

Access to resources Recommend Favorite

Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment

By Peñarrubia Joana  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 915-922

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

By Friedler S.   Raziel A.   Schachter M.   Strassburger D.   Bukovsky I.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1944-1948

Oxford University Press

Access to resources Recommend Favorite

Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI

By Abdel Mohsen Iman   Ezz El Din Rasha  

Gynecological Endocrinology, Vol. 29, Iss. 2, 2013-02 ,pp. : 105-108

Informa Healthcare

Access to resources Recommend Favorite

Hypoglycemia does not affect gonadotroph responsiveness to gonadotropin-releasing hormone in rhesus monkeys

By Lujan Marla   Krzemien Alicja   Vugt Dean  

Endocrine Journal, Vol. 21, Iss. 2, 2003-07 ,pp. : 109-114

Humana Press, Inc

Access to resources Recommend Favorite